Patents Assigned to Vivacelle Bio, Inc.
  • Compositions and methods for reducing reperfusion injury
    Patent number: 10716756
    Abstract: A pharmaceutical composition comprising a lipid component, an amphiphilic emulsifier, a polar liquid carrier, and one or more electrolytes, where the amphiphilic emulsifier forms lipid carrying micelles having a lipophilic core comprising the lipid component in the polar liquid carrier, and/or liposomes organized as a lipid bilayer and/or other particle configurations. The pharmaceutical composition is free of hemoglobin and fluorocarbon and can be used for treating ischemic conditions with reduced reperfusion injury.
    Type: Grant
    Filed: June 15, 2017
    Date of Patent: July 21, 2020
    Assignee: Vivacelle Bio, Inc.
    Inventor: Cuthbert O. Simpkins
  • COMPOSITIONS AND METHODS FOR REDUCING REPERFUSION INJURY
    Publication number: 20190151244
    Abstract: A pharmaceutical composition comprising a lipid component, an amphiphilic emulsifier, a polar liquid carrier, and one or more electrolytes, where the amphiphilic emulsifier forms lipid carrying micelles having a lipophilic core comprising the lipid component in the polar liquid carrier, and/or liposomes organized as a lipid bilayer and/or other particle configurations. The pharmaceutical composition is free of hemoglobin and fluorocarbon and can be used for treating ischemic conditions with reduced reperfusion injury.
    Type: Application
    Filed: June 15, 2017
    Publication date: May 23, 2019
    Applicant: VIVACELLE BIO, INC.
    Inventor: Cuthbert O. SIMPKINS
  • Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
    Patent number: 9622968
    Abstract: A pharmaceutical composition comprising an amphiphilic emulsifier, a polar liquid carrier and, optionally, a lipid component. The amphiphilic emulsifier form free-moving, optionally lipid-carrying, micelles (LMs) in the polar liquid carrier. The pharmaceutical composition is free of hemoglobin and fluorocarbon and can be used for treating conditions related to lack of blood supply and to raise the blood pressure and correct hypovolemia.
    Type: Grant
    Filed: November 6, 2014
    Date of Patent: April 18, 2017
    Assignee: VIVACELLE BIO, INC.
    Inventor: Cuthbert O. Simpkins
  • Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
    Patent number: 9439855
    Abstract: A pharmaceutical composition comprising an amphiphilic emulsifier, a polar liquid carrier and, optionally, a lipid component. The amphiphilic emulsifier form free-moving, optionally lipid-carrying, micelles (LMs) in the polar liquid carrier. The pharmaceutical composition is free of hemoglobin and fluorocarbon and can be used for treating conditions related to lack of blood supply and to raise the blood pressure and correct hypovolemia.
    Type: Grant
    Filed: November 6, 2014
    Date of Patent: September 13, 2016
    Assignee: Vivacelle Bio, Inc.
    Inventor: Cuthbert O. Simpkins
  • Methods and compositions for treating conditions related to lack of blood supply, shock, and neuronal injuries
    Patent number: 9387162
    Abstract: A pharmaceutical composition comprising a lipid component; an amphiphilic emulsifier; and a polar liquid carrier. The lipid component and the amphiphilic emulsifier form free-moving lipid-carrying micelles (LMs) in the polar liquid carrier. The pharmaceutical composition is free of hemoglobin and fluorocarbon and can be used for treating conditions related to lack of blood supply and to raise the blood pressure.
    Type: Grant
    Filed: November 21, 2013
    Date of Patent: July 12, 2016
    Assignee: VIVACELLE BIO, INC.
    Inventor: Cuthbert O. Simpkins
  • Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
    Patent number: 8906855
    Abstract: A pharmaceutical composition comprising an amphiphilic emulsifier, a polar liquid carrier and, optionally, a lipid component. The amphiphilic emulsifier form free-moving, optionally lipid-carrying, micelles (LMs) in the polar liquid carrier. The pharmaceutical composition is free of hemoglobin and fluorocarbon and can be used for treating conditions related to lack of blood supply and to raise the blood pressure and correct hypovolemia.
    Type: Grant
    Filed: August 9, 2013
    Date of Patent: December 9, 2014
    Assignee: Vivacelle Bio, Inc.
    Inventor: Cuthbert O. Simpkins